PXS-5446

N/A

Report date: 2023/04/02 18:55:19
NME

Base Information

Drug NamePXS-5446
Drug Alias NamePXS-5446
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysyl oxidase inhibitors
TargetsLysyl oxidase
Therapy Area/IndicationsPrimary Myelofibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSyntara Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Myelofibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A